Patents Assigned to CLOVIS ONCOLOGY, INC.
  • High dosage strength tablets of rucaparib
    Patent number: 10130636
    Abstract: A tablet including high dosage of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one camsylate salt has been disclosed.
    Type: Grant
    Filed: March 14, 2018
    Date of Patent: November 20, 2018
    Assignee: Clovis Oncology, Inc.
    Inventor: Jeffrey Etter
  • High dosage strength tablets of rucaparib
    Patent number: 9987285
    Abstract: A tablet including high dosage of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one camsylate salt has been disclosed.
    Type: Grant
    Filed: August 17, 2015
    Date of Patent: June 5, 2018
    Assignee: CLOVIS ONCOLOGY, INC.
    Inventor: Jeffrey Etter
  • METHOD FOR SELECTION OF CHEMOTHERAPEUTIC AGENTS FOR ADENOCARCINOMA CANCER
    Publication number: 20130116209
    Abstract: The subject invention relates to determining the presence and level of hENT1 expression in tumor tissue that is appropriate for gemcitabine therapy, and more importantly, the level of hENT1 expression that signifies that treatment with a gemcitabine derivative is a more appropriate strategy.
    Type: Application
    Filed: August 2, 2012
    Publication date: May 9, 2013
    Applicants: VENTANA MEDICAL SYSTEMS, INC., CLOVIS ONCOLOGY, INC.
    Inventors: Jeffrey Dean Isaacson, Mical Raponi, James Ranger-Moore, Eric L. Powell
  • METHOD FOR SELECTION OF CHEMOTHERAPEUTIC AGENTS FOR ADENOCARCINOMA CANCER
    Publication number: 20130115628
    Abstract: The subject invention relates to determining the presence and level of hENT1 expression in tumor tissue that is appropriate for gemcitabine therapy, and more importantly, the level of hENT1 expression that signifies that treatment with a gemcitabine derivative is a more appropriate strategy.
    Type: Application
    Filed: August 2, 2012
    Publication date: May 9, 2013
    Applicants: VENTANA MEDICAL SYSTEMS, INC., CLOVIS ONCOLOGY, INC.
    Inventors: Jeffrey Dean Isaacson, Mical Raponi, James Ranger-Moore, Eric L. Powell